Senior Director, HTA, Value and Evidence, Oncology, Pipeline

HTA, Value And Evidence Oncology Pipeline Senior Director

The HTA, Value and Evidence Oncology Pipeline Senior Director will support the strategic goals of the Oncology Division by driving optimal clinical development strategy and access evidence generation focused on maximizing patient access for oncology assets currently in development. This role directly impacts the ability to achieve business objectives on a global basis by providing strategic guidance and robust access evidence development relevant to achieve optimal patient access by demonstrating the value of our oncology pipeline. The HTA, Value and Evidence Senior Director will be responsible for independently leading the evidence generation strategy, including execution and dissemination of technical deliverables that support the value of pipeline assets. The HTA, Value and Evidence Senior Director will work closely with cross functional colleagues to ensure robust strategies are in place for optimal HTA submissions and price negotiations. This position will function in a closely aligned fashion with the Oncology and pipeline Global Access & Value (GAV) team members to ensure there is a single and coordinated view on strategy and delivery from the GAV team to the broader Oncology Division.

Role Responsibilities

• Lead the development of access evidence generation strategy to support the value of Pfizer's Oncology pipeline assets, in close partnership with the cross-functional matrix team.
• Lead the coordination of input from local country / regional teams on evidence needs and ensure that the input is appropriately incorporated to develop and integrate the access evidence strategy to support global market access needs at launch and through lifecycle.
• Lead the timely development of early launch deliverables including early global value dossiers, value and evidence strategy, integrated evidence plan, systematic literature reviews, early economic models, predictive analytics for value and evidence, and innovative tools to successfully support reimbursement and access requirements in conjunction with the regions / countries.
• Lead the design and execution of global HEOR studies (e.g., network meta-analyses, real-world evidence) from concept through publication.
• Develop patient-reported outcomes strategy and incorporate humanistic and economic endpoints into clinical trials across all phases of product development to build comprehensive trial-based evidence in line with overall medical strategy for the assets and to ensure global reimbursement and access requirements.
• Provide strategic input in the selection of relevant patient population and comparators within clinical trials to enable successful negotiations, reimbursement, and appropriate patient access with global payer and regulatory decision makers.
• Identify opportunities to partner with external stakeholders to conduct Value and Evidence projects in support of the oncology pipeline assets.
• Partner with other GAV cross functional colleagues to ensure strategic alignment and successful / timely execution of projects.
• Develop strategic partnerships and research collaborations with key external experts, healthcare policy makers, payers, and various academic and community oncology settings to support asset strategies.

Basic Qualifications

Candidate demonstrates a breadth of diverse leadership experiences and capabilities including : the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.

Other Job Details :